Sodium-dependent Glucose Co-transporter 2 (SGLT 2) Market Share

Statistics for the 2023 & 2024 Sodium-dependent Glucose Co-transporter 2 (SGLT 2) market share, created by Mordor Intelligence™ Industry Reports. Sodium-dependent Glucose Co-transporter 2 (SGLT 2) share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Pharmaceuticals Research Active Pharmaceutical Ingredients Research General Pharmaceuticals Research Hyperglycemics Research SGLT2 Inhibitors Market Market Share

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Sodium-dependent Glucose Co-transporter 2 (SGLT 2) Industry

The Sodium-dependent Glucose Co-transporter 2 (SGLT 2) Market is highly consolidated, with a few significant manufacturers having a global market presence. The companies strengthen their market presence by getting approval in new forms.

SGLT2 Inhibitors Market Leaders

  1. Janssen Pharmaceuticals

  2. Eli Lilly

  3. Bristol Myers Squibb

  4. AstraZeneca Pharmaceuticals

  5. Astellas

*Disclaimer: Major Players sorted in no particular order

Sodium-dependent Glucose Co-transporter 2 (SGLT 2) Market Concentration

SGLT2 Drugs Market Report Snapshots

SGLT2 Inhibitors Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)